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Background: The toxic heavy metal lead continues to be a leading environmental risk factor, with the number of
attributable deaths having doubled between 1990 and 2010. Although major sources of lead exposure, in particular
lead in petrol, have been significantly reduced in recent decades, lead is still used in a wide range of processes and
objects, with developing countries disproportionally affected. The objective of this systematic review is to assess the
effectiveness of regulatory, environmental and educational interventions for reducing blood lead levels and
associated health outcomes in children, pregnant women and the general population.
Methods/design: The databases MEDLINE, Embase and the Global Health Library (GHL) will be searched using a
sensitive search strategy. Studies in English, German, French, Spanish, Italian or Afrikaans will be screened according
to predefined inclusion and exclusion criteria. We will consider randomized and non-randomized studies accepted
by the Cochrane Effective Practice and Organization of Care (EPOC) Group, as well as additional non-randomized
studies. Screening of titles and abstracts will be performed by one author. Full texts of potentially relevant studies
will be independently assessed for eligibility by two authors. A single author will extract data, with a second reviewer
checking the extraction form. Risk of bias will be assessed by two researchers using the Graphical Appraisal Tool for
Epidemiological studies, as modified by the Centre for Public Health at the UK National Institute for Health and Care
Excellence. Any inconsistencies in the assessment of eligibility, data extraction or quality appraisal will be resolved through
discussion. Where two or more studies report the primary outcome blood lead levels within the same population group,
intervention category and source of lead exposure, data will be pooled using random effects meta-analysis. In parallel,
harvest plots as a graphical method of evidence synthesis will be used to present findings for blood lead levels and
secondary outcomes.
Discussion: This systematic review will fill an important evidence gap with respect to the effectiveness of interventions to
reduce lead in consumer products and drinking water in the context of new WHO guidelines for the prevention and
management of lead poisoning. It will also contribute to setting a future research agenda.Background
Description of the health problem
Lead is a toxic heavy metal that causes extensive environ-
mental contamination due to its environmental persistence
and transportability [1]. It has become widely distributed in
the environment - especially due to industrialization and
mining activities - whereby human exposure has steadily* Correspondence: pfadenh@ibe.med.uni-muenchen.de
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article, unless otherwise stated.increased [2]. Lead is one of the leading environmental risk
factors, with the number of attributable deaths having dou-
bled between 1990 and 2010 [3].
In most developed countries, a clear reduction in
blood lead levels (BLL) occurred over the past decades,
mainly due to phasing out of leaded petrol. In the US,
the prevalence of elevated BLL (≥10 g/dL ) in children
aged one to five years decreased from 8.6% in 1988 to
1991 to 1.4% in 1999 to 2004, constituting a 84% de-
cline, with geometric mean BLLs being lowest in non-ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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tween 1978 and 1988, marked decreases in the average
blood lead levels of adults were noted in many countries,
including Belgium, the Federal Republic of Germany, New
Zealand, Sweden, and the United Kingdom [5]. While
cases of acute lead poisoning have become rare in devel-
oped countries, continuous exposure to low levels of lead
is still a public health issue, especially among ethnic mi-
norities and socio-economically disadvantaged groups [6].
Although awareness is increasing, lead exposure remains
a significant public health problem in developing coun-
tries, particularly due to the fact that regulations and pol-
icies are missing [7]. Differences between major sources of
exposure are observed: paint is a major source of lead ex-
posure in the US, while lead-glazed ceramics impose a sig-
nificant health risk in Latin America [8]. Children living in
Africa are still exposed to the highest levels of lead in
petrol as well as to lead released by burning of paper prod-
ucts, discarded rubber, battery casings, and painted wood
for cooking and heating [9]. In various countries in Africa
and South East Asia, as well as in China, lead-based paint
is readily available for sale, with 78% of the sample of 80
paints bought in China (100%), India (72%), Malaysia
(56%) and Singapore (9%) containing more than 600 ppm
of lead [10]. In 2009, an additional sample of 300 lead-
based paints was collected, including eight additional
countries from Africa, Asia and South America. In all
countries, high lead content in paint was observed [11].
Occurrence of lead
Lead can be found in a variety of natural as well as anthropo-
genic sources. It has a natural occurrence in the Earth’s crust,
and is released by volcanic activities, geochemical weathering
and sea spray emissions, as well as by the remobilization of
historic sources (soil, sediment, water from mining areas)
[12]. Considerable amounts of lead were discharged during
industrialization. The blood lead concentration in pre-
industrial humans is estimated to have been 0.016 μg/dL, a
level which is 50- to 200-fold lower than the lowest reported
level in people living in remote regions of the Southern and
Northern hemisphere today [13]. In all countries that have
banned leaded gasoline, average population blood lead levels
have declined rapidly [5]. With respect to anthropogenic
sources of lead today, 40% of lead is being used as pure
metal, 25% in alloys (for example tin, antimony, bismuth,
brass, bronze, steel) and 35% in chemical compounds [14].
Unlike in acute lead intoxication, where the respective
source of lead exposure can usually be identified, longer-
term, persistent exposure to lead is more complex, due
to the large variety of sources and pathways.
Lead in consumer products
The use of lead in consumer products constitutes a
major source of exposure. Lead is added intentionally tocertain consumer products for its perceived therapeutic
effect, for the coloration it imparts to the products as
well as for adding weight to spices sold by weight [15].
The US Centers for Disease Control and Prevention
(CDC) identified candy, folk and traditional medicines,
ceramic dinnerware, children’s jewellery, clothing orna-
ments, children’s toys, key chains and other metallic or
painted objects as well as products including vinyl, plas-
tic and rubber as potential sources of lead [16].
Paint is a common source of exposure to lead [17]. Es-
pecially when renovating, dust and chips from chipping
or chalking of lead-based paints present a source of lead
exposure. Lead paint is contained in window frames,
walls, the outside of homes, or other surfaces. Some 80%
of the global annual primary (mining) and secondary (re-
cycling) lead consumption occurs in the production of
lead batteries or accumulators [18]. Batteries provide a
major source of lead poisoning in developing countries,
where they are often recycled in small shops or back-
yards or are illegally disposed of. Toys and cheap jewel-
lery may be painted with lead-based paint or be made of
lead-contaminated materials [19,20]. Various cases of
contaminated toys, as well as Halloween and Easter
products, were reported recently, leading to a large-scale
recall of toys imported from China to the US [21]. The
CDC, moreover, issued a warning on imported candies.
Lead is either added through ingredients such as chili or
tamarind, the production process (drying, storing, grind-
ing) or in the wrapping [22]. Chocolate and candy sold
in India also tested positive for heavy metals, including
lead [23], as was the wrapping in Korea, [24], Taiwan
[25] and Mexico [26]. Illicitly distilled beverages (moon-
shine), which constitute a major source of alcohol intake
worldwide (about 30%, [27]) are oftentimes produced in
makeshift distilling units containing harmful toxins, such
as lead [28]. Lead-glazed earthenware, glasses and other
dishes were also reported to be responsible for lead ex-
posure [29], which is of particular relevance in Latin
American countries [8]. Moreover, lead is often used in
a variety of cosmetics, such as lipsticks and eye cos-
metics, including the traditional Indian eye cosmetic
‘surma’ [30,31] or ‘sindoor’, which is both used as a food
additive and as a cosmetic [32]. A European survey of
lead content in lipsticks and lip gloss revealed that 49
out of 223 lip articles (22%) sold in 15 EU member states
contained more than 1 mg/kg lead [33]. Lead and other
heavy metals were detected in traditional Indian Ayur-
vedic medicines, which are also sold in the US [34-36].
Several cases of lead poisoning caused by unbranded
Ayurvedic medicines have been reported [36].
Lead in water
While water constitutes a relatively minor source of
daily lead intake for adults, it may be a greater source of
Table 1 Signs and symptoms associated with lead toxicity
[14]
Mild toxicity Moderate toxicity Severe toxicity
Myalgia and
paraesthesia
Arthralgia Paresis and paralysis
Mild fatigue General fatigue Colic
Irritability Difficulty concentrating Lead line (blue-black)
on gingival tissue
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According to the US Environmental Protection Agency
(USEPA), 20% of the lead exposure of children can be at-
tributed to lead-contaminated water [38], and the con-
centration of lead in water is correlated with BLL in
children [39].
Large concentrations of lead are rarely present in nat-
urally occurring water bodies or treated water [40]. Lead
particles, which accumulate in soil, can be flushed out
by rain, contaminating rivers, lakes and streams. How-
ever, concentrations are relatively low, as is the likeli-
hood of lead contaminating groundwater – except for
rainwater being acidic or ‘soft’ (containing few or no
minerals) [41].
Yet, elevated lead concentrations in water are often ob-
served as the result of corrosive water effects on materials
used in distributing water: plumbing, coating, solder, pipes
and pipe joints and fittings [40]. Lead concentrations are de-
termined by various factors, such as pH, temperature, water
hardness and standing time of the water, with soft, acidic
water being the most plumbosolvent [40,42]. When water
distribution systems are irregularly used, the interior of the
lead service pipes is exposed to air. Scale that has built up
over the years becomes brittle and flakes away. When water
flows through the pipes again or when lead service pipes are
damaged or undergo maintenance [43], lead is dissolved,
causing contamination of drinking water [44].
Human health response
In contrast to elements such as iron or zinc, which are
essential for human nutrition, lead is both non-essential
and toxic for the human body [45]. The main routes of
exposure are ingestion and inhalation.
Lead is available as organic lead (that is containing
carbon) and inorganic lead (that is not containing car-
bon). While inorganic lead crosses the less-developed
blood-brain barrier in children, organic lead penetrates
the blood-brain barrier even in adults, leading to en-
cephalopathy, one symptom of severe acute lead poison-
ing [46]. Inorganic lead entering the human body is not
metabolized, but absorbed, distributed and excreted dir-
ectly. The absorption rate depends on the chemical and
physical form, as well as on the condition of the exposed
person. Inhaled lead is completely absorbed, while the
rate ranges between 10 and 15% for ingested lead. This
rate is higher for pregnant women and children where
up to 50% is absorbed. Infants and young children ab-
sorb about 40 to 50% of ingested water-soluble lead
(adults 3 to 10%). Evidence suggests that this amount
may increase to 50 to 60% during fasting where lead is
ingested on an empty stomach [47].
While the CDC formerly defined levels above 10 μg/dl
as elevated concentrations of lead in blood [48], they
now use a reference level for children of 5 μg/dL, whichis based on the 97.5th percentile of children’s blood lead
concentrations in the US [49]. However, no evidence of
a threshold exists [50,51].
The human organism can be exposed to high concen-
trations of lead on an acute basis (that is acute lead poi-
soning), or to lower concentrations of lead over a period
of months or years (that is chronic lead poisoning).
Table 1 illustrates the signs and symptoms associated
with acute lead poisoning. Chronic lead poisoning, on
the other hand, is hard to diagnose, since symptoms are
non-specific and similar to those of many other disor-
ders. Evidence on low and moderate exposure to lead
points to subtle or subclinical effects, especially affecting
the neuropsychological development of children [52].
The cumulative toxicant affects neurological, haemato-
logical, gastrointestinal, musculoskeletal, cardiovascular,
renal and reproductive systems [12,53]. No matter
whether lead enters the body through ingestion or inhal-
ation, the subsequent physiological effects are similar.Neurological response
The nervous system is particularly sensitive to lead, with
damage seeming to be irreversible [54]. Acute, high-level
lead exposure (that is blood lead concentrations in excess
of 100 μg/dL) presents as acute severe encephalopathy.
The effects on the central nervous system (CNS) may in-
clude dullness, irritability, poor attention span, headache,
muscular tremor, seizures, coma and death in children
[55]. Childhood exposure to lead is inversely linked to in-
tellectual abilities, academic achievement, and psycho-
motor development [56-59]. Exposure to low or moderate
lead levels is associated with deficits in attention, language,
Table 2 Global disability-adjusted life years (DALYs)
attributable to lead (both sexes, all ages, 2010) [83]
DALYs attributable





Non-communicable diseases 53.88% 1.04%








Hypertensive heart disease 0.62% 9.48%
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visual-motor integration, as well as aggression [58-62].
Renal response
Lead is associated with acute and chronic nephropathy, de-
pending on the exposure period and the level of lead [63].
Chronic nephropathy can lead to chronic renal dysfunction
(for example, kidney failure, chronic kidney disease, hyper-
uricemia and gout) and dysfunction of the immune system
[64-67]. Besides, studies have shown an association between
blood lead levels and blood pressure (see below), with
hypertension being a cardinal feature of lead nephropathy
[65]. Recent evidence also points to low-level environmen-
tal lead exposure – levels common also in developed coun-
tries – being associated with reduced kidney function, even
in the absence of other co-morbidities [68].
Reproductive response
Lead is a reproductive toxicant. In men, lead is associated
with impaired spermatogenesis, chromosomal damage, in-
fertility, abnormal prostatic function and changes in serum
testosterone. In women, it is associated with miscarriage,
premature membrane rupture, pre-eclampsia, pregnancy
hypertension and premature delivery. It can also lead to in-
fertility in women [69]. At low-lead exposure, elevations in
maternal blood pressure during labour and delivery have
been observed [70].
Cardiovascular response
Even low-level exposure to lead is associated with car-
diovascular effects [71,72]. High concentrations of lead,
as they occur during occupational exposure, are toxic to
both the heart and vascular smooth muscles [73]. Occu-
pational as well as environmental exposures to lead are
associated with arterial hypertension [74-77]. Lead poi-
soning during childhood is likely to cause clinically sig-
nificant hypertension, which is considered a cause of
arterial hypertension [78]. Evidence suggests there is a
link with clinical cardiovascular outcomes, such as car-
diovascular and coronary heart disease, stroke mortality
and peripheral arterial disease [79].
Burden of disease attributable to lead
The effects of low lead exposures on mortality have been
widely studied, especially in large cohort studies [71].
For example, the US National Health and Nutrition
Examination Survey (NHANES) showed that adults aged
30 to 74 years with baseline blood lead levels of 20 to
29 μg/dL had 46% increased all-cause mortality (39% in-
creased circulatory mortality, 68% increased cancer mor-
tality) [80]. A 2009 cohort study conducted in the US
showed increased mortality, especially from coronary
heart disease, in women with BLLs >8 μg/dL [81]. A fur-
ther 2009 cohort study in an environmentally exposedpopulation with low blood lead levels suggests that bone
lead is associated with all-cause and cardiovascular mor-
tality. In this study, bone lead was not associated with
cancer, and blood lead was not associated with any mor-
tality category [82].
Globally, around 1% of the total disability-adjusted life
years (DALYs) are attributable to lead exposure, with devel-
oping countries being disproportionally affected (1.14%
compared to 0.72% in developed countries) [83]. Around
1% of global deaths are attributable to lead (651,632 deaths)
[84]. Table 2 shows the risk factor attribution of lead to the
share of non-communicable diseases; lead appears to be a
significant cause of hypertensive heart disease.
Vulnerable groups
Lead exposure is ubiquitous. Thus the whole population
is potentially exposed, especially people living in lower
socio-economic neighbourhoods, namely in old houses,
post-industrial areas or in close proximity to mining and
smelting areas or highways.
Children up to six years of age are particularly suscep-
tible to adverse health effects of lead through a combin-
ation of greater exposure, greater absorption and
retention and greater developmental vulnerability [85].
Increased risk of lead exposure is determined by expos-
ure during pregnancy (lead crosses the placenta) [86,87],
increased intake of food, water and air relative to body
weight, risk behaviour (for example, hand-to-mouth be-
haviour), and more time spent in polluted environments
(for example, home) [1,37,88,89]. The absorption of lead
is four to five times higher in children than in adults (ex-
cluding pregnant women), and only 30% of the absorbed
lead is excreted, while 70% is accumulated in bone,
blood, brain, kidneys, liver and lungs [45]. Finally, expos-
ure may occur during windows of developmental vulner-
ability, and children have more time to develop late
consequences of lead intake.
A similar vulnerability applies to pregnant and nursing
women due to the mobilization of lead stored in bones,
which applies to women who are chronically exposed to
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[90,91]. The bone resorption also presents an endogen-
ous source of lead during lactation where the maternal
body responds to the calcium needs of the infant [91].
BLLs change during pregnancy and the postpartum
period, with levels being significantly higher postpartum
[91]. Lead affects a wide range of processes critical to
the development of the CNS, including myelination [92],
differentiation [93] and synaptogenesis [94].
Description of the intervention
Different interventions are available to reduce exposure
to lead in consumer products and drinking water. For
the purposes of this review, these are categorized as
regulatory interventions, environmental interventions
and educational interventions.
Regulatory interventions
Regulatory interventions are legislation and regulations
used by governments around the world to protect their
citizens against health and safety risks derived from
lead-contaminated consumer products and drinking
water. Standards for lead have been introduced since the
late-1970s, starting off with phasing lead out of petrol.
Regulations, product bans and testing requirements
intended to prevent acute or chronic exposure to lead in
paint, ambient air, drinking water, workplace environ-
ments and consumer products followed. These are
intended to limit the amount of lead allowed in drinking
water, ban the use of lead in solder and plumbing com-
ponents, and require the replacement of lead pipes in
water systems if they fail to meet a specified testing
standard. Regulations phasing out or banning uses of
lead in consumer products have led to reductions in
BLLs [95].
Lead in drinking water has been recognized as an im-
portant source of lead intake for decades. The current
provisional World Health Organization (WHO) guide-
line is 10 μg/L [40].
Environmental interventions
Environmental interventions include but are not re-
stricted to engineering, filtering and treating measures,
which aim to eliminate lead exposure by repairing or re-
moving water distribution systems or elements thereof
by reducing corrosion and lead-leaching corrosivity in
water systems [44]. To our knowledge, there are no en-
vironmental interventions aimed at reducing lead in
consumer products.
The repairing or removal of leaded pipes is cost-
intensive [44], with full lead service line replacement be-
ing preferable to partial replacement since the latter
might disturb the pipes and knock off lead-bearing pipe
scale [96]. Lead can moreover be removed chemically ortechnically at the water system level, at the point of entry to
the residence or at the point of use. Means to remove lead
include filters (for example, reverse osmosis filters, distilla-
tion), absorbers (for example, zeolites, resins, or activated
carbon) [97] and chemicals (for example, phosphoric acid,
ortho-phosphoric acid polyphosphate, silicates). Also, che-
mical additives that increase pH and alkalinity (optimal pH
range 7.5 to 9.5; optimal alkalinity range 30 to 75 mg/l) can
reduce corrosion and lead solubility and thereby reduce
lead concentrations in drinking water [98].
Educational interventions
Educational interventions can include information on
sources of lead in consumer products and drinking
water, health sequelae of lead, and lead exposure reduc-
tion strategies, including household cleaning, safe use of
water, hygiene, and nutrition. These may be directed at
protecting both adults and children.
Interventions may include information campaigns that
inform parents or the general public about consumer
products possibly contaminated with lead, about how to
exercise informed product choice and about how to use
products correctly.
Interventions aiming at behaviour changes may pro-
mote actions, such as letting the water run before use,
especially in old buildings, whose plumbing has not been
restored in the past 50 years, or avoiding drinking water
from the hot tap, since this water may contain higher
concentrations of lead than cold water. In order to en-
sure the safety of baby formula, it should not be pre-
pared with contaminated tap water [99].
How the intervention might work
Interventions to reduce exposure to lead through con-
sumer products and drinking water must often be car-
ried out over an extended period of time and may
involve multiple governmental sectors including envir-
onment, transport, water, housing and health. Also, such
interventions may not lead to immediate changes in hu-
man exposure or health outcomes. This, as well as the
complexity of the environmental and biological pathways
leading to a health response, complicates the assessment
of the effects of such interventions. In order to help
understand the relationship between lead interventions
and elevated BLLS and to structure and guide the review
process, we developed the system-based logic model in
Figure 1, based on methodological work undertaken as
part of the EU-funded INTEGRATE-HTA project (Anke
Rohwer, personal communication).
Why it is important to do this review
Lead as a ubiquitous pollutant is responsible for a sub-
stantial disease burden [66], and disproportionately af-
fects the developing world; 99% of the severest cases of
Figure 1 System-based logic model for interventions to reduce exposure to lead through consumer products and drinking water.
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[100]. The health outcomes associated with lead also
show stark inequalities in exposure and health effects for
disadvantaged groups within industrialized and develop-
ing countries. Despite sharp reductions in the general
population’s exposure to lead since the 1970s, substantial
numbers of ethnic minority and low-income children
continue to exhibit unacceptably high BLLs [101,102].
To our knowledge, no systematic review has been under-
taken to assess the effectiveness of interventions to re-
duce lead in consumer products and drinking water,
although a systematic review has been conducted for
household interventions for preventing domestic lead
exposure in children [89]. This review is undertaken in
the course of the development of WHO guidelines for
the prevention and management of lead poisoning.
Objectives
The objective of this systematic review is to assess the
effectiveness of regulatory, environmental and educa-
tional interventions for reducing blood lead levels and
associated health outcomes in children, pregnant women
and the general population.
Methods/design
This systematic review is not registered with PROSPERO.Criteria for considering studies for this review
Types of studies
Due to the range of lead interventions, we will consider
both randomized and certain non-randomized studies
for this review. In doing so, we will distinguish between
those non-randomized studies accepted by the Cochrane
Effective Practice and Organization of Care (EPOC)
Group [103] and additional non-randomized studies.
The following study designs will therefore be eligible for
inclusion:
 Individually randomized trials
 Cluster randomized trials
 Controlled before-and-after studies adhering to
EPOC standards (CBA-EPOC) – with at least two
intervention sites and two control sites
 Interrupted time series studies adhering to EPOC
standards (ITS-EPOC) – with at least three data
points before and after a clear intervention point
 Controlled before-and-after studies not adhering to
EPOC standards (CBA) – with less than two inter-
vention and/or control sites
 Uncontrolled before-and-after studies (UBA)
 Interrupted time series studies not adhering to
EPOC standards (ITS) – with less than three data
points before and after a clear intervention point
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intervention point and effect data taken both before
and after the intervention
As we expect inconsistencies in naming among studies,
we will be very careful not to exclude studies solely based
on study design labels. A cohort study, for example, in
which a clear intervention point exists and an assessment
is undertaken both pre- and post-intervention, is essen-
tially an uncontrolled before-and-after study according to
our definitions.
Types of participants
We will consider studies where children, pregnant
women and/or adults are included. We restrict our par-
ticipants to people who are not occupationally exposed
to lead.
Types of interventions
Interventions aiming to reduce exposure to lead through
consumer products (including cans, ceramic ware, jewel-
lery, toys, cosmetics, traditional medicines, paint) and
drinking water are categorized according to their re-
spective programmatic approach. Interventions specific-
ally aiming to reduce exposure to leaded paint will be
excluded, as their effectiveness was assessed in a recent
Cochrane review [89].
 Regulatory interventions (for example, standards for
lead, product bans, product testing requirements)
 Environmental interventions (for example, removal
of leaded pipes, additives to reduce lead solubility,
water filters)
 Educational interventions (for example, restricted




The primary outcome of this review is blood lead level.
Blood lead levels, measured in μ/dl, can be assessed in
venous blood samples or capillary blood samples. Effect
estimates may be reported as continuous measures (for
example, mean or median blood levels for a given popu-
lation) or categorically (for example, percentage of popu-
lation with blood lead levels above a defined threshold).
Secondary outcomes
Among children, two secondary outcomes will be assessed:
the critical short-term outcome will be acute lead poison-
ing. Symptoms of acute lead poisoning include gastrointes-
tinal (anorexia, nausea, vomiting, abdominal pain, consti-
pation, metallic taste) and nervous system symptoms (poor
concentration, headache, fatigue, malaise, language andspeech delay, behavioural problems, encephalopathy, ataxia,
seizure, coma). Physical examination can reveal signs of
raised intracranial pressure, lead lines in teeth, gout and
hypertension. The diagnosis of lead poisoning is confirmed
through laboratory tests showing elevated blood lead levels,
hypochromic anaemia, red blood cells with basophilic stip-
pling, elevated protoporphyrin levels, elevated transaminase
levels, and proteinuria, glucosuria and aminoaciduria in
urine [15]. An important long-term outcome is cognitive
and neurobehavioural development, as measured by stan-
dardized measures of intelligence quotient, behaviour and
development. These include the Stanford Binet Intelligence
Scale, Wechsler Intelligence Scale for Children, Wechsler
Preschool and Primary Scale of Intelligence, Kaufman Test
of Educational Achievement (K-TEA) for the assessment of
intelligence, the Griffiths Mental Development Scales and
the Child Behaviour Checklist.
In relation to pregnant women, pregnancy outcomes
(miscarriage, stillbirth, premature birth, low birth weight,
minor malformations of the embryo [104]) will be assessed.
Among adolescents and adults, outcomes to be docu-
mented are hypertension and renal problems, as assessed
mainly by the glomerular filtration rate.
Adverse events
We will also carefully examine included studies for any
adverse events reported. An adverse event is defined as
any unfavourable outcome that occurs during or after
the delivery of the intervention but is not necessarily
caused by it [105]. For example, an adverse outcome
would be contamination of drinking water with other
chemicals as a consequence of water treatment changes
aimed at reducing lead concentrations [97].
Search methods for identification of studies
Sources to search




 Global Health Library
Designing the search strategy
The databases will be searched using the intervention,
intermediary agent and outcome search terms described
in Table 3; these groups of search terms will be con-
nected using the Boolean operator AND. Search terms
for individual databases will be modified as necessary to
meet the requirements of any changes to indexing terms
or database platforms. Searches will be conducted in
English. The eligibility of studies published in English,
German, French, Spanish, Italian or Afrikaans will be
assessed by the review team itself; for any studies
Table 3 Search strategy
Exposure/outcome Intermediary agent Intervention
‘Blood lead level’ Product Reduction*
‘blood lead’ Products Reduce*
‘BLL’ Production Control
‘B-Pb’ ‘consumer product*’ Intervent*
Lead [MeSH] Can Regulat*
‘Pb’ Cans Legislat*
‘Lead poison*’ Jewellery Politic*
‘Lead poisoning’ [MeSH] Jewelry Policy
‘Lead intoxication’ Toy* Policies
‘Lead toxicity’ Candy Government*
Plumbism Candies ‘government
regulation’ [MeSH]
Saturnism Alcohol Guideline [MeSH]
‘colicapictonum’ Alcoholic Educat*
‘lead sulphide’ ‘ceramic ware’ ‘health warning*’













































*The asterix denotes truncation: for the truncated term, all possible suffix
variations will be retrieved.
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tify assistance with their assessment for eligibility. Table 3
describes general search terms, while the explicit search
strategy can be found in Additional file 1.
Data collection and analysis
Selection of studies
Screening of titles and abstracts will be performed by one
author, that is one of Lisa Pfadenhauer (LP), Anke Rohwer
(AR) and Jake Burns (JB). At this stage, only studies that
are clearly not appropriate for inclusion will be excluded.
Certain details regarding study design and features are
often not as well reported in non-randomized studies
when compared with randomized controlled trials. If cer-
tain key criteria for inclusion cannot be ascertained from
title or abstract, the study will be kept for full-text
screening.
Full texts of seemingly relevant studies will be assessed
for eligibility by two authors (that is two of LP, AR, JB
and Eva Rehfuess (ER)). Disagreements between the two
reviewers will be resolved through discussion, and a
third reviewer will be consulted where necessary. Re-
viewers will document reasons for exclusion.
Data extraction and management
LP, JB or AR will extract data using a tabular extraction
form. The data extraction form will be checked by a sec-
ond reviewer. Inconsistencies or disagreements between
reviewers will be resolved through discussion, and ER
will be consulted where necessary. We will record infor-
mation and effect estimates for all primary and second-
ary outcomes reported by the study.
As significant differences between interventions are ex-
pected, we will focus on extracting all relevant data to
thoroughly describe the intervention. For each interven-
tion, we will extract the intervention components (related
Table 4 Possible responses to individual items in
modified Graphical Appraisal Tool for Epidemiological
studies (GATE)
++ Indicates that for that particular aspect of study
design, the study has been designed or
conducted in such a way as to minimise
the risk of bias.
+ Indicates that either the answer to the checklist
question is not clear from the way the study is
reported, or that the study may not have
addressed all potential sources of bias for that
particular aspect of study design.
− Should be reserved for those aspects of the
study design in which significant sources of
bias may persist.
Not reported (NR) Should be reserved for those aspects in which
the study under review fails to report how they
have (or might have) been considered.
Not applicable (NA) Should be reserved for those study design
aspects that are not applicable given the study
design under review (for example, allocation
concealment would not be applicable for case
control studies).
GATE, Graphical Appraisal Tool for Epidemiological Studies.
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and policies as specified in the logic model in Figure 1) as
well as intervention execution (dose, duration, intensity
and timing) and delivery aspects (level of implementation,
delivery agent, organization and structure).
Relevant contextual and implementation data, based on
a context and implementation framework developed as
part of the EU-funded INTEGRATE-HTA project (Lisa
Pfadenhauer, personal communication), will be extracted,
where available. This framework places important context-
ual domains within the setting, community, national and









Also, data that could highlight possible health inequality
issues arising during implementation or any time thereafter
will be extracted. This will be based upon the PROGRESS
framework [106], which includes place, race, occupation,
gender, religion, education and socio-economics.
Quality appraisal of included studies
The quality of included studies will be independently
assessed by two researchers (two of LP, JB, AR), using
the modified Graphical Appraisal Tool for Epidemio-
logical studies (GATE) tool [107], as tailored to public
health questions and applied by the Centre for Public
Health at the UK National Institute for Health and Care
Excellence (NICE) [108]. The two versions of this tool –
one for quantitative intervention studies, one for quanti-
tative studies reporting correlations and associations –
can be applied across all experimental and observational
study designs.
For intervention studies, the appraisal checklist com-
prises key aspects exerting influence on internal and ex-
ternal validity:
 characteristics of study participants
 definition of, and allocation to, intervention and
control conditions
 outcomes assessed over different time periods
 methods of analyses.
The checklist embraces five sections. Section 1 aims to
describe key population criteria in order to assess the ex-
ternal validity of the study, while Sections 2 to 5 deter-
mine the internal validity of the study. The wording ofthe checklist items allows five responses, as shown in
Table 4.
Interrupted time series, uncontrolled before-and-after
studies and repeated cross-sectional studies will be
treated as quantitative studies reporting correlations and
associations. The modified GATE for these studies re-
sembles the modified GATE for intervention studies, but
emphasizes selection of the exposure group and statis-
tical control for confounding rather than intervention al-
location and blinding [108].
Each intervention and correlational study is then
awarded an overall rating of likely internal and external
validity, based on the criteria depicted in Table 5.Measures of treatment effect
We will present dichotomous data using risk ratios. For
continuous data using arithmetic means, geometric
means or medians, we will present mean or median dif-
ferences. All results will be presented with their associ-
ated 95% confidence intervals.Unit of analysis issues
If the included cluster randomized controlled trials have
sufficiently accounted for the cluster design, we will in-
clude the effect estimates in the meta-analysis, combin-
ing them with individually randomized trials. If
clustering has not been addressed, we will attempt to ad-
just the data for clustering by inflating the standard er-
rors by multiplying them by the square root of the
design effect [105]. We will then include the adjusted ef-
fect estimates in the meta-analysis.
Table 5 Overall rating of internal and external validity in




All or most of the checklist criteria have been fulfilled, where they
have not been fulfilled the conclusions are very unlikely to alter.
+ Some of the checklist criteria have been fulfilled, where they have
not been fulfilled, or not adequately described, the conclusions are
unlikely to alter.
− Few or no checklist criteria have been fulfilled and the conclusions
are likely or very likely to alter.
GATE, Graphical Appraisal Tool for Epidemiological Studies.
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In the case that missing information on study features,
intervention characteristics or outcome data prevent fur-
ther use of a study, investigators will be contacted.
Assessment of heterogeneity
Issues of clinical and methodological heterogeneity will
be assessed in tabular form for studies in each of the
three intervention categories, with the documentation of
the following study-specific characteristics:
 Methods: study design, group assignment, exposure
assessment, outcome assessment, result of critical
appraisal
 Participants: setting (industrialized vs. developing;
urban vs. rural), age
 Context and implementation: based on the above
mentioned context and implementation for complex
interventions framework (Lisa Pfadenhauer, personal
communication).
Statistical heterogeneity will be assessed with an I2 cal-
culation in Revman 5.2 [109]. An I2 value greater than
50% will be considered substantial, and will be consid-
ered statistically significant if the P value for the chi2 test
is <0.1.
Assessment of reporting biases
We will assess likely reporting biases through the use of
funnel plots for outcomes that are reported in more than
10 studies.
Data synthesis
Where at least two studies report the same primary out-
come within the same population group (that is children,
pregnant women, adults), intervention category and
source of lead exposure, we will pool data using meta-
analysis. For studies with multiple comparison groups,
only those comparisons assessing an intervention/inter-
vention component compared with no intervention/
intervention component will be analysed. In the main
analysis, we will pool across all study designs.Due to expected differences in intervention compo-
nents and complexity, setting and study population,
random-effects models will be implemented for all
meta-analyses independent of substantial or limited stat-
istical heterogeneity. Inverse-variance random-effects
meta-analyses will be carried out using Revman 5.2
[109]. Effects will be considered statistically significant
where a P value of less than 0.05 is found.
As we expect much of the evidence to be too heteroge-
neous for statistical pooling, harvest plots will be devel-
oped in parallel to meta-analysis. Harvest plots are a
novel form of synthesizing evidence – especially in sys-
tematic reviews of complex interventions [110,111] and
have been shown to be effective, clear and transparent
[112]. Harvest plots will be used to graphically synthesize
evidence based on all study designs for the effects of
regulatory, environmental and educational intervention
categories across all primary and secondary outcomes,
where the direction of effect is illustrated by columns
(left-hand column: favours control, middle column: no
differences, right-hand column: favours intervention).
Two sets of harvest plots will be created. The first set
will portray the primary outcome BLL with the interven-
tion category and source of lead exposure shown in rows
(that is environmental interventions to reduce lead in
consumer products, environmental interventions to re-
duce lead in drinking water, and so on). Each study is
represented by a bar, and identified by the first three let-
ters of the author’s last name. The colours indicate the
study population (black for children, grey for pregnant
women, and white for the general population). Also il-
lustrated, by height of bar, will be appropriateness of
study design with randomized and cluster randomized
trial being assigned the greatest height, followed by
EPOC-recognized designs (intermediate height) and
other non-randomized designs (lowest height). The sym-
bols employed with the modified GATE (++, +, −) will
indicate the degree of internal validity for each study.
The second set will develop separate harvest plots for
each intervention category in relation to exposure, pre-
senting findings for all primary and secondary outcomes.
Here separate rows will present the primary outcome
BLL and the five secondary outcomes (that is acute lead
poisoning, cognitive and neurobehavioural outcomes,
pregnancy outcomes, hypertension and renal outcomes).
Harvest plots will be created in Microsoft PowerPoint.
Subgroup analysis
In order to assess possible sources of heterogeneity, sub-
group analyses for the primary outcome BLL may be
performed for drinking water interventions (intervention
through water authority or at household level) and in re-
lation to context characteristics, although we expect that
lack of data will prevent these from being conducted.
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Where possible, we will conduct the following sensitivity
analyses for the primary outcome BLL in relation to
study design:
 Meta-analysis based on lower risk of bias study
designs only, that is individually and cluster
randomized trials as well as CBA-EPOC and ITS-
EPOC studies.
 Harvest plots based on lower risk of bias study
designs only, that is individually and cluster
randomized trials as well as CBA-EPOC and ITS-
EPOC studies.
Data permitting, we will also dichotomize continuous
measures of BLL using 5 μg/dl (or the threshold most
widely used across included studies) as the threshold
value, and pool all data for this new dichotomous
outcome.
The insights derived from these sensitivity analyses
will be compared to those gained through the main
synthesis.
Discussion
This systematic review will fill an important evidence
gap with respect to the effectiveness of interventions to
reduce lead in consumer products and drinking water in
the context of new WHO guidelines for the manage-
ment and prevention of lead poisoning. It will also con-
tribute to setting a future research agenda.
Additional file
Additional file 1: Search Strategies. Description of data: the additional
file provides the explicit search strategy employed for the systematic
search in EMBASE, MEDLINE and the Global Health Library.
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